摘要
为提升全市临床研究能力,提高临床研究质量,增强医药健康产业高质量发展的溢出效应,2020年北京市推行示范性研究型病房建设并从工作机制和受试者保护方面对伦理委员会工作提出了需求。作为研究型病房建设的服务支撑,伦理委员会应在推进多中心临床研究伦理审查结果互认、加强受试者招募管理上积极探索,持续改进。
In order to enhance Beijing’s clinical research capabilities,improve the quality of clinical research,and enhance the spillover effect of the high-quality development of the pharmaceutical and health industry.In 2020,Beijing promoted the construction of demonstration research wards,and put forward requirements for the working mechanism of Institutional Review Boards (IRBs) and the practice of subject protection.IRBs,as services supporting for the construction of research ward,should be committed to promoting mutual recognition of Ethical Review on multi-center clinical research,and reinforcing the management of subject recruitment,which needs to improve continuously.
作者
张卓然
李小莹
李晓玲
王香平
赵国光
ZHANG Zhuoran;LI Xiaoying;LI Xiaoling;WANG Xiangping;ZHAO Guoguang(Xuanwu Hospital,Capital Medical University,No.45,Changchun Street,Xicheng District,Beijing,100053,PRC)
出处
《中国医院》
北大核心
2021年第10期39-41,共3页
Chinese Hospitals
关键词
研究型病房
医院伦理
伦理审查
结果互认
受试者招募
research ward
Institutional Review Boards(IRBs)
ethical review
mutual recognition
subject recruitment